Global Market Market Outlook Market Report Market Reports

Global Bio pharma Buffer Market Is Expected To Grow At A CAGR of 7.2% From 2020 to 2027

Biopharma buffers are used to resist change in the pH and ionic concentration of biochemical process under clinical investigation, buffers basically comprise of acid and base conjugates. Henderson-Hasselbalch equation is critical in determining the pH of the buffer solutions such as acetates, phosphates, carbonates, organic buffers, etc.

Phosphate buffers are presently dominating the type segment for the biopharma buffer market on account of increasing demand from the life science industry and academic research institutes. The major factors responsible for its huge popularity among researchers is its pH, osmolarity, and ionic concentration similar to the human bodily fluids. It is used as the diluent, rinse containers containing cells, reference spectrum to measure protein adsorption on ellipsometry. Acetate buffers are widely employed in molecular biology especially in the purification and precipitation of nucleic acids. Organic buffers will be showcasing magnificent market growth on account of increasing demand for novel drug development such as vaccines, immunotherapy, biologics, etc.

Browse the full report Bio Pharma Buffer Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at

The biopharmaceutical industry is currently leading the end-user segment for the biopharma buffer market. Significant rise in the spread of virulent diseases such as ebola, COVID-19, swine flu, etc. creates the burgeoning requirement for the development of vaccines and novel drugs to prevent the spread and reduce the mortality rate associate with the viral infections. Academia and research institutes worldwide are keen to register rampant market growth owing to the strategic collaboration between pharmaceutical companies to promote breakthrough research and technology to serve mankind. Huge monetary funds provided by governmental healthcare agencies to establish academic research institutes.

North America is currently representing the largest market share in the geography segment for the biopharma buffer market. The key attributes associated with its market dominance are proactive role adopted by healthcare agencies to promote research and development activities for the treatment of infectious and lifestyle disorders in the region. The existence of well-developed healthcare infrastructure and constantly growing biopharmaceutical segments together drive the biopharma buffer market in the region. Europe is in the 2nd position in the regional market for the biopharma buffer market. Increasing demand for the discovery of novel vaccines and immunotherapy to treat infectious and autoimmune disease further propel the biopharma buffer market growth in the region. The Asia Pacific is anticipated to register comfortable market growth during the forecast period on account of developing healthcare infrastructure and flourishing drug formulation and development market.

Biopharmaceutical companies actively engaged in the manufacturing of biopharma buffer are Merck KGaA.,Thermo Fisher Scientific, Bio-Rad Laboratories, Inc., Lonza, Becton Dickinson and Company, Promega Corporation, GE Healthcare, ANGUS Chemical Company, Takara Bio, Inc., and VWR International, LLC.

Market Key Takeaways:

  • Significant increase in the drug development activities across the life science industry
  • Rising prevalence of infectious disease creates a burgeoning requirement of novel drug discovery and vaccine development to curb its fatality
  • The constant rise in the academic research institutes worldwide to promote breakthrough research and technology to cater to the medical needs of mankind

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Email: [email protected]

Global Market

Global Bio Pharma Buffer Market , Trends, Analysis, Opportunities, Share and Forecast – 2019-2025

In this report,global Bio Pharma Buffer Market will reach 929.47 Million USD by the end of 2022 with a CAGR of 7.81%

“The global Bio Pharma Buffer market was valued at 638.29 Million USD in 2017 and will reach 929.47 Million USD by the end of 2022, growing at a CAGR of 7.81% during 2017-2022.”

A buffer solution is comprised of a weak conjugate acid-base pair, for example, a weak acid and its conjugate base, or a weak base and its conjugate acid. Small quantities of other acids or bases are neutralized when added to the solution, and as a result, the solution resists changes in pH. Solutions with stable pH are required for the processing of protein-based biologic APIs because of their sensitivity to changes in pH. The stable pH range and capacity (the amount of acid/base that can be added without a change in pH) of a buffer are determined by the conjugate acid-base pair.

Bio Pharma Buffer can be divided into four categories: Phosphates Type, Acetates Type and TRIS Type. Phosphates Type accounted for the highest proportion in revenue market, with a figure of 28.68% in 2017, followed by TRIS Type, account for 22.65% and Acetates Type account for 13.33%.

The sales market share of global Bio Pharma Buffer in Research Institution use, \Pharmaceutical Industry use and other applictions have been stable year by year, at 42.10%, 50.48% and 7.42% respectively in 2017, and for several consecutive years, the amplitude was within one percent. This indicates that the segment of the Bio Pharma Buffer in the global market tends to be fixed without great changes. Among them, the Bio Pharma Buffer market has the most promising sales prospects in Pharmaceutical Industry use.

XYZ research center data shows that North America is the biggest contributor to the Bio Pharma Buffer revenue market, accounted for 47.35% of the total global market with a revenue of 302.21 million USD in 2017, followed by Europe, 27.90% with a revenue of 178.10 million USD.

Merck is the largest company in the global Bio Pharma Buffer market, accounted for 20.82% of the revenue market share in 2017, followed by Avantor and Alfa Aesar (Thermo Fisher), accounted for 18.19% and 16.45% of the revenue market share in 2017. According to the revenue of these companies, we can know that the Bio Pharma Buffer industry is relative concentrated. Because the top 6 companies have more than 70% market share in 2016.

Geographically, global Bio Pharma Buffer market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Alfa Aesar (Thermo Fisher)
GE Healthcare
Promega Corporation
Hamilton Company

On the basis of product, we research the production, revenue, price, market share and growth rate, primarily split into
Phosphates Type
Acetates Type
For the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Bio Pharma Buffer for each application, including
Research Institution
Pharmaceutical Industry
Production, consumption, revenue, market share and growth rate are the key targets for Bio Pharma Buffer from 2014 to 2026 (forecast) in these regions
Southeast Asia
South America

If you have any special requirements, please let us know and we will offer you the report as you want.

To request a sample copy or view summary of this report, click the link below:

About Digits N Markets:

Digits N Markets has a vast repository of latest market research reports on trending topics, niche company profiles, market size and other relevant data released by renowned publishers. We have access to the database related to niche markets and trending topics in various industries. We also update the data regularly to provide recent statistics to the client. Recent data and reports will be featured on our websites and clients will be able to access the same. Our clients will be able to benefit from qualitative & quantitative insights in the report which will support them in taking concrete business decisions.

Contact Us :

Digits ‘N’ Markets
410 E Santa Clara Street, Unit #762
San Jose, CA 95113
Phone :+1 408-622-0123
Email: [email protected]